Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy.
Ingrosso G, Detti B, Fodor A, Caini S, Borghesi S, Triggiani L, Trippa F, Russo D, Bruni A, Francolini G, Lancia A, Marinelli L, Di Muzio N, Livi L, Magrini SM, Maranzano E, Musio D, Aristei C, Valeriani M.
Ingrosso G, et al. Among authors: maranzano e.
Clin Transl Oncol. 2021 Aug;23(8):1577-1584. doi: 10.1007/s12094-021-02553-5. Epub 2021 Jan 25.
Clin Transl Oncol. 2021.
PMID: 33495981